SynthesisInvestigational new drugs2023

The efficacy and safety of selective RET inhibitors in RET fusion-positive non-small cell lung cancer: a meta-analysis.

Jun-Yi Ke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.